Table 2.
Compares between baseline characteristics and effect of treatment after 2 months among participants
| Group | P value | ||||||
|---|---|---|---|---|---|---|---|
| A | B | ||||||
| Median | Minimum | Maximum | Median | Minimum | Maximum | ||
| IIEF-5a | 24 | 22 | 33 | 24 | 22 | 25 | 0.621e |
| AIPE baselineb | 19 | 9 | 20 | 19.5 | 8 | 30 | 0.41e |
| IELT baseline (Sec)c | 60 | 30 | 120 | 60 | 30 | 120 | 0.577e |
| Male SQOL baselined | 20 | 15 | 30 | 21 | 16 | 33 | 0.294e |
| AIPE after treatmentb | 26 | 9 | 34 | 19.5 | 8 | 30 | < 0.001e |
| IELT after treatment (Sec)c | 180 | 30 | 240 | 60 | 30 | 120 | < 0.001e |
| Male SQOL after treatmentd | 45 | 18 | 55 | 21 | 16 | 33 | < 0.001e |
aIIEF-5 the international index of erectile function
bAIPE the Arabic index of premature ejaculation
cIELT Intravaginal ejaculatory latency time
dMale SQOL (sexual quality of life questionnaire- male version) before and after treatment in both placebo and treatment groups
eP value was calculated using Mann Whitney U test